Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Galapagos NV (GLPG)

117.03   4.39 (3.9%) 05-21 16:00
Open: 116.54 Pre. Close: 112.64
High: 117.2 Low: 116.15
Volume: 74,791 Market Cap: 6448M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 117.255 - 117.963 117.963 - 118.642
Low: 114.458 - 115.3 115.3 - 116.107
Close: 115.743 - 116.98 116.98 - 118.165

Technical analysis

as of: 2019-05-21 4:27:20 PM
Overall:       
Stoxline posted a STRONG BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 140.81     One year: 164.47
Support: Support1: 114.60    Support2: 110.92
Resistance: Resistance1: 120.56    Resistance2: 140.81
Pivot: 114.30
Moving Average: MA(5): 114.22     MA(20): 114.03
MA(100): 106.14     MA(250): 104.36
MACD: MACD(12,26): 0.34     Signal(9): 0.50
Stochastic oscillator: %K(14,3): 50.91     %D(3): 44.31
RSI: RSI(14): 57.07
52-week: High: 125.48  Low: 85.00  Change(%): 16.7
Average Vol(K): 3-Month: 12556  10-Days: 9676

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
GLPG has closed below upper band by 4.7%. Bollinger Bands are 60.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to GLPG's normal range. The bands have been in this narrow range for 11 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Sun, 19 May 2019 19:07:45 Z
Better Buy: Vertex Pharmaceuticals vs. Galapagos

Sun, 12 May 2019 14:07:31 Z
Is It Finally Time to Buy Gilead Sciences?

Thu, 02 May 2019 15:12:02 Z
Better Buy: Vertex Pharmaceuticals vs. Galapagos

Tue, 30 Apr 2019 15:06:35 Z
Will Gilead Stock Get A Needed Boost From This Week’s Earnings Report?

Sat, 27 Apr 2019 03:10:46 Z
Galapagos NV (GLPG) Q1 2019 Earnings Call Transcript

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 54.61
Shares Float (M) 54.61
% Held by Insiders
% Held by Institutions 21.50
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS
EPS Est. Current Year -2.760
EPS Est. Next Year -3.550
EPS Est. Next Quarter -1.080
Forward EPS -4.349
Book Value (p.s.) 4.740
PEG Ratio
Profit Margin -14.43
Operating Margin
Return on Assets (ttm) -3.1
Return on Equity (ttm) -3.9
Qtrly Rev. Growth -8.7
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

P/E
P/E Growth Ratio
P/BV 24.69
P/S
P/CF

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.